Valuation: Medpace Holdings, Inc.

Market Cap 15.6B 13.67B 12.61B 11.65B 22.11B 1,491B 22.51B 151B 58.81B 731B 58.59B 57.3B 2,536B P/E 2026 *
31.4x
P/E 2027 * 28.7x
Enterprise Value 14.43B 12.64B 11.66B 10.78B 20.45B 1,379B 20.82B 140B 54.4B 676B 54.2B 53.01B 2,346B EV / Sales 2026 *
5.2x
EV / Sales 2027 * 4.74x
Free-Float
80.38%
Yield 2026 *
-
Yield 2027 * -
1 day-2.62%
1 week+0.45%
Current month+0.45%
1 month+17.11%
3 months+4.62%
6 months-13.23%
Current year-5.28%
1 week 520.88
Extreme 520.88
567.91
1 month 445
Extreme 445.005
567.91
Current year 373
Extreme 373
628.92
1 year 306.7
Extreme 306.7035
628.92
3 years 227.21
Extreme 227.21
628.92
5 years 126.94
Extreme 126.945
628.92
10 years 21.76
Extreme 21.76
628.92
Manager TitleAgeSince
Chief Executive Officer 69 1992-06-30
Director of Finance/CFO 51 2021-07-31
Chief Tech/Sci/R&D Officer 65 2017-08-31
Director TitleAgeSince
Chairman 69 1992-06-30
Director/Board Member 55 2016-06-30
Director/Board Member 72 2016-06-30
Date Insider Type Main position Quantity % Market Cap.
06-29Fiscal year

Director

56 0.0002%
06-29Fiscal year

Director

72 0.0003%
06-29Fiscal year

Director

66 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-2.62%+0.45%+66.82%+125.87% 15.6B
-0.24%+4.98%+2.69%+9.14% 49.74B
-0.36%+1.33%+417.51%+619.10% 40.49B
-2.29%+5.93%+25.27%+59.26% 34.35B
-2.13%+5.47%+25.45%-6.01% 34.75B
-0.79%+2.02%+3.83%+36.42% 26.98B
+3.82%+3.92% - - 16.58B
-2.17%+6.52%+102.15%+102.15% 14.27B
-2.70%-2.19%+11.25%+18.19% 13.76B
-1.93%-4.74%+12.11%-30.02% 12.92B
Average -1.14%+3.30%+74.12%+103.79% 25.95B
Weighted average by Cap. -1.04%+4.01%+89.37%+130.17%

Financials

2026 *2027 *
Net sales 2.77B 2.43B 2.24B 2.07B 3.93B 265B 4B 26.87B 10.46B 130B 10.42B 10.19B 451B 2.95B 2.58B 2.38B 2.2B 4.18B 282B 4.25B 28.57B 11.12B 138B 11.07B 10.83B 479B
Net income 493M 432M 398M 368M 698M 47.07B 711M 4.77B 1.86B 23.08B 1.85B 1.81B 80.1B 540M 473M 436M 403M 765M 51.6B 779M 5.23B 2.04B 25.3B 2.03B 1.98B 87.79B
Net Debt -1.17B -1.02B -945M -873M -1.66B -112B -1.69B -11.32B -4.41B -54.77B -4.39B -4.29B -190B -1.62B -1.42B -1.31B -1.21B -2.29B -155B -2.33B -15.67B -6.1B -75.8B -6.08B -5.94B -263B
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,300
Date Price Change Volume
26-07-08 US$531.99 -2.62% 347,444
26-07-07 US$546.29 -3.33% 357,572
26-07-06 US$565.09 +1.34% 234,162
26-07-02 US$557.60 +2.58% 356,575
26-07-01 US$543.57 +2.64% 312,635
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
546.29USD
Average target price
451.42USD
Spread / Average Target
-17.37%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEDP Stock